Literature DB >> 10764717

Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis.

C Chapoutot1, M Esslimani, Z Joomaye, J Ramos, P Perney, C Laurent, P Fabbro-Peray, D Larrey, J Domergue, F Blanc.   

Abstract

BACKGROUND: Liver iron deposits are frequent in viral C cirrhotic patients but their role is not well defined. AIMS: To investigate the effect of liver iron excess on the prevalence of hepatocellular carcinoma (HCC) in patients with viral C cirrhosis.
METHODS: Hepatic iron was evaluated retrospectively using a semiquantitative method in liver biopsies of 104 viral C cirrhotic patients, 48 with HCC and 56 controls (HCC free). Corrected total iron score (0-60) was defined by the sum of three scores: hepatocytic iron score (0-36), sinusoidal iron score (0-12), and portal iron score (0-12), multiplied by 3/3, 2/3, or 1/3 according to the heterogeneous iron localisation in the nodules.
RESULTS: After adjustment for known risk factors for HCC, regression analysis showed that iron deposits (corrected total iron score >0) were more frequent in HCC patients than in controls (odds ratio 4.94; 95% confidence interval 1.59-15. 32; p=0.0056). The median of corrected total iron score was significantly higher in HCC patients than in controls (odds ratio 1. 092; 95% confidence interval 1.01-1.13; p=0.021). This liver iron overload was sinusoidal (odds ratio 5.2; 95% confidence interval 1. 82-15.11; p=0.0022).
CONCLUSIONS: Liver iron deposition was more frequent and more important in viral C cirrhotic patients with HCC than in HCC free controls. Liver iron overload seems to contribute to the development of HCC in patients with viral C cirrhosis.

Entities:  

Mesh:

Year:  2000        PMID: 10764717      PMCID: PMC1727940          DOI: 10.1136/gut.46.5.711

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C.

Authors:  T L Fong; M Shindo; S M Feinstone; J H Hoofnagle; A M Di Bisceglie
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 2.  Iron and neoplasia.

Authors:  Y Deugnier; B Turlin; O Loréal
Journal:  J Hepatol       Date:  1998       Impact factor: 25.083

3.  Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations.

Authors:  Y M Deugnier; O Loréal; B Turlin; D Guyader; H Jouanolle; R Moirand; C Jacquelinet; P Brissot
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  Impact of alcohol on the histological and clinical progression of hepatitis C infection.

Authors:  T E Wiley; M McCarthy; L Breidi; M McCarthy; T J Layden
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

5.  [Histologic quantification of hemochromatotic and non-hemochromatotic liver siderosis. A stidu of 254 liver biopsies].

Authors:  B Turlin; I Robert; S Maugendre; F Le Gall; P Brissot; M P Ramée; Y Deugnier
Journal:  Ann Pathol       Date:  1997-10       Impact factor: 0.407

6.  Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group.

Authors: 
Journal:  Lancet       Date:  1998-05-23       Impact factor: 79.321

7.  Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

Authors:  B C Smith; J Gorve; M A Guzail; C P Day; A K Daly; A D Burt; M F Bassendine
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

8.  The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization.

Authors:  P P Anthony; K G Ishak; N C Nayak; H E Poulsen; P J Scheuer; L H Sobin
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

9.  Liver cell dysplasia: a premalignant condition.

Authors:  P P Anthony; C L Vogel; L F Barker
Journal:  J Clin Pathol       Date:  1973-03       Impact factor: 3.411

10.  Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens.

Authors:  D A Shafritz; D Shouval; H I Sherman; S J Hadziyannis; M C Kew
Journal:  N Engl J Med       Date:  1981-10-29       Impact factor: 91.245

View more
  14 in total

Review 1.  Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

Authors:  Abdel-Rahman El-Zayadi; Mahmoud Anis
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

2.  Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.

Authors:  Suleyman Uraz; Cem Aygun; Abdullah Sonsuz; Gulsen Ozbay
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

3.  3,5,5-trimethyl-hexanoyl-ferrocene diet protects mice from moderate transient acetaminophen-induced hepatotoxicity.

Authors:  Mi Sun Moon; Boo-Hyon Kang; Jacek Krzeminski; Shantu Amin; Cesar Aliaga; Junjia Zhu; Emily I McDevitt; Susan Kocher; John P Richie; Harriet C Isom
Journal:  Toxicol Sci       Date:  2011-09-09       Impact factor: 4.849

4.  ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1.

Authors:  Tong Zhang; Linchong Sun; Yijie Hao; Caixia Suo; Shengqi Shen; Haoran Wei; Wenhao Ma; Pinggen Zhang; Ting Wang; Xuemei Gu; Shi-Ting Li; Zhaolin Chen; Ronghui Yan; Yi Zhang; Yongping Cai; Rongbin Zhou; Weidong Jia; Fang Huang; Ping Gao; Huafeng Zhang
Journal:  Nat Cancer       Date:  2021-12-09

Review 5.  Iron-Induced Hepatocarcinogenesis-Preventive Effects of Nutrients.

Authors:  Hiroyuki Tsuchiya
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

Review 6.  The role of iron in the pathophysiology and treatment of chronic hepatitis C.

Authors:  Leslie Price; Kris V Kowdley
Journal:  Can J Gastroenterol       Date:  2009-12       Impact factor: 3.522

Review 7.  Alcoholic liver disease and hepatitis C: a frequently underestimated combination.

Authors:  Sebastian Mueller; Gunda Millonig; Helmut K Seitz
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

8.  Reduced serum hepcidin levels in patients with chronic hepatitis C.

Authors:  Domenico Girelli; Michela Pasino; Julia B Goodnough; Elizabeta Nemeth; Maria Guido; Annalisa Castagna; Fabiana Busti; Natascia Campostrini; Nicola Martinelli; Italo Vantini; Roberto Corrocher; Tomas Ganz; Giovanna Fattovich
Journal:  J Hepatol       Date:  2009-08-12       Impact factor: 25.083

9.  Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC.

Authors:  Yanyan Wei; Wei Ye; Wei Zhao
Journal:  Front Physiol       Date:  2018-02-06       Impact factor: 4.566

Review 10.  Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.

Authors:  Driton Vela
Journal:  Mol Med       Date:  2018-03-15       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.